Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032762HBVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS10059189HBVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30014568HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30077154HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30024844HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS20068134HPVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS44007688HTLV-1ENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS43000129MCVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TCGA Plot Options
Drug Information
GeneATP1A1
DrugBank IDDB13996
Drug NameMagnesium acetate
Target IDBE0000732
UniProt IDP05023
Regulation Type
PubMed IDs16808357; 16928192; 16990961; 17294093
CitationsBuchachenko AL, Kuznetsov DA, Berdinskii VL: [New mechanisms of biological effects of electromagnetic fields]. Biofizika. 2006 May-Jun;51(3):545-52.@@Sirijovski N, Olsson U, Lundqvist J, Al-Karadaghi S, Willows RD, Hansson M: ATPase activity associated with the magnesium chelatase H-subunit of the chlorophyll biosynthetic pathway is an artefact. Biochem J. 2006 Dec 15;400(3):477-84.@@Balasubramaniyan V, Nalini N: Leptin alters brain adenosine triphosphatase activity in ethanol-mediated neurotoxicity in mice. Singapore Med J. 2006 Oct;47(10):864-8.@@Nogovitsina OR, Levitina EV: Neurological aspects of the clinical features, pathophysiology, and corrections of impairments in attention deficit hyperactivity disorder. Neurosci Behav Physiol. 2007 Mar;37(3):199-202.
GroupsApproved
Direct ClassificationAcetate salts
SMILES[Mg++].CC([O-])=O.CC([O-])=O
Pathways
PharmGKB
ChEMBLCHEMBL1200691